Klaim, Inc.
PrivateLast Round
Strategic
Oct 27, 2025
Total Funding Raised
$35.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Klaim, Inc. is a healthcare-fintech company that provides an AI-powered payment acceleration platform designed to improve cash flow efficiency for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Vertical SaaS, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Payment Processing Fee, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Klaim, Inc. Comparables
Compare Klaim, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santechture | 83% | |
| ACCUMED Practice Management | 76% | |
| Adonis | 74% | |
Klaim, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 27, 2025 | ||||
| Series A | Mar 8, 2025 | ||||
| Debt | Mar 8, 2025 | ||||
| Seed | Nov 17, 2022 | ||||
| Seed | Sep 7, 2021 | ||||
Seed | Mar 16, 2021 |
Key People
Founding team and executive leadership
Klaim, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Seed |
| Knuru Capital | Seed |
| Wealth Well | Seed |
| Mad'a Investment Company | Seed, Series A |
| Arzan Venture Capital | Seed |
| CDG Invest | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 136% MoM, reaching 3.9K.
- Apr 20, 2026
Monthly visitors increased 287% MoM, reaching 4.8K.
Klaim, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Klaim, Inc.'s valuation, stock price, and market status.